• Return to Headlines

Shares of Bluebird Bio Inc Fall Below Previous 52-Week Low

By Shiri Gupta

Bluebird Bio Inc (NASDAQ:BLUE) traded today at a new 52-week low of $125.02. Approximately 163,000 shares have changed hands today, as compared to an average 30-day volume of 647,000 shares.

Bluebird Bio, Inc. provides biotechnological products and services. The Company offers gene therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders, and beta-thalassemia. Bluebird Bio conducts its business in the United States.

In the past 52 weeks, Bluebird Bio Inc share prices have been bracketed by a current low of $125.02 and a high of $236.17 and are now at $125.75. Over the last five market days, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has declined 1%.

There is potential upside of 70.5% for shares of Bluebird Bio Inc based on a current price of $125.75 and an average consensus analyst price target of $214.38. Bluebird Bio Inc shares should first meet resistance at the 50-day moving average (MA) of $151.42 and find additional resistance at the 200-day MA of $175.58.

SmarTrend recommended that its subscribers protect gains by selling shares of Bluebird Bio Inc on September 6th, 2018 by issuing a Downtrend alert when the shares were trading at $157.14. Since that call, shares of Bluebird Bio Inc have fallen 18.7%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: 52 week high/lows bluebird bio inc

Ticker(s): BLUE